Back

Inflammatory and diabetic conditions trigger SHP2 tyrosine phosphatase expression and subsequent aberrant activation of primary human monocytes

28 August 2022 (10:15 - 11:00)
Organised by:
Congress Presentation Part of: Novel insights into vascular inflammation Leukocytes, Inflammation, Immunity ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Marc Dorenkamp

University Hospital Munster - UKM, Muenster (Germany)

6 More presentations in this session

Presentation thumbnail
Atherosclerosis licenses for an exceeding immune response in COVID-19 disease
Mr J. Leberzammer (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Citrullination of histoneH3 in neutrophil via CXCL1 enhances neutrophil adhesion to femoral artery of LDLR-/- mice fed HFD
Professor M. Yoshida (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Early stage atherosclerosis regression using combined sonotherapy and mitoxantrone- mediated sonoporation therapy
Doctor H. Mehrad (Tabriz, IR)
Abstract Slides
Presentation thumbnail
GLP-1 receptor expression in human internal thoracic arteries is dependent on low-grade inflammation potentially explaining the cardiovascular protective effect of GLP1-R agonists
Doctor E. Cordeanu (Strasbourg, FR)
Abstract Slides
Presentation thumbnail
Leptin mediates protective effects on the vasculature
Miss V. Filipova (Leipzig, DE)
Abstract Slides

Access the full session

Session thumbnail
Novel insights into vascular inflammation

The Event

Event poster

ESC Congress 2022

28 August 2022 10:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources